IBD patients have been found to have a higher risk of lymphoma.

Published Date: 26 Apr 2023

According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.

Read Full News

Latest News

Optimizing Treatment Access and Outcomes for Patients With Eosinophilic Esophagitis: A Regional Workshop Series Aligning Payer and Clinician Approaches

Optimizing Treatment Access and Outcomes for Patients With Eosinophilic Esophagitis: A Regional Workshop Series Aligning Payer and Clinician Approaches

Trump Cuts Mask True Extent of Cyclospora Outbreaks

Source of infection still unknown in several other cyclosporiasis clusters

'Practice-Changing' Data Expand Zanidatamab's Approval to Gastroesophageal Cancer

Bispecific antibody plus chemo with or without tislelizumab improves OS, PFS versus trastuzumab

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

RAS inhibitor daraxonrasib doubled survival outcomes in second-line trial

Nonsurgical Options for Early Rectal Cancer Continue to Show Promise

60-80% of patients avoided surgery for a year or longer in trial

GI Doc Awakes to Bat in Mouth; Stopped Farting? Uh-Oh; FDA Approves GERD Implant

News and commentary from the world of gastroenterology and hepatology

Todays Updates

Selution SLR Drug-Eluting Balloon Gets FDA Nod for Coronary In-Stent Restenosis

— Rival to the Agent DCB had been shown noninferior to DES

Todays Updates

Selution SLR Drug-Eluting Balloon Gets FDA Nod for Coronary In-Stent Restenosis

— Rival to the Agent DCB had been shown noninferior to DES

Latest News

Optimizing Treatment Access and Outcomes for Patients With Eosinophilic Esophagitis: A Regional Workshop Series Aligning Payer and Clinician Approaches

Source of infection still unknown in several other cyclosporiasis clusters

Bispecific antibody plus chemo with or without tislelizumab improves OS, PFS versus trastuzumab

RAS inhibitor daraxonrasib doubled survival outcomes in second-line trial

60-80% of patients avoided surgery for a year or longer in trial

News and commentary from the world of gastroenterology and hepatology

News All Time

The Challenge of Diagnosing Abdominal Pain and Diarrhea

Did the young woman have IBD, IBS, or infection?

Less Frequent Colonoscopy After Polyp Removal Could Be the Way to Go, Study Suggests

Findings show similar incidence of colorectal cancer with colonoscopy at 3 and 5 years

Ulcerative Colitis With an Unexpected Cause

Can the immune response to COVID-19 trigger inflammatory bowel disease?

What Is Causing This Constellation of Symptoms in a 57-Year-Old Man?

Stomach pain, wheezing, and night sweats add up to a diagnosis of a rare but increasing condition

Brain Disorder Due to Vitamin Deficiency Often Goes Unrecognized

Korsakoff syndrome was hard to diagnose and frequently led to death

Pamela Anderson's Hepatitis; Statins After Colon Cancer; Fall Vaccines in Gastro/Hep

News and commentary from the world of gastroenterology and hepatology

Study Assesses Who's at Risk for Young-Onset MASLD Cirrhosis

Younger patients appear to have a combo of genetic susceptibility and metabolic risk factors

3 Common Drugs Older Adults Might Be Overusing

— "They're easy to start, but they can be hard to stop," says one expert

Endoscopy AI Faces a Skill and Trust Reckoning

Does AI promote deskilling in gastroenterologists? How should human-AI workflows be designed in the endoscopy suite? How should clinicians calibrate and validate AI-based tools?

Nurse-Led Program Reduces Death Anxiety in Breast Cancer

A structured nurse-led support program combining in-person and virtual sessions reduces death anxiety among women with breast cancer undergoing hormonal therapy, a study reports.

US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee

US Health Secretary Robert F. Kennedy Jr. on Thursday named eight new members to the advisory panel that decides which preventive medical care, such as routine cancer...

Are Vaginal Probiotics Actually Doing Anything?

Clinical evidence varies by probiotic strain, formulation, dose, and treatment setting, while broad wellness claims may encourage self-diagnosis and delay appropriate care.

Americans Pop Probiotics but Skip the Fiber, Experts Warn

Probiotic supplement use increased substantially among US adults and children from 2009 to 2023; however, dietary fiber intake remained well below recommended levels.

US Declares End Of Largest Recorded Cyclosporiasis Outbreak

U.S. health authorities on Friday declared the nation's largest recorded multistate cyclosporiasis outbreak over, after contaminated iceberg lettuce sickened thousands,...

New AGA Guidance on Cancer Surveillance in Seniors

New guidance says continuing surveillance should factor in comorbidities, life expectancy, risks vs benefits, and surgical tolerance levels, as well as patient preferences.

Bowel Cancer Under 50: Rethinking Screening and Diagnosis

Australia has the highest rate of bowel cancer in the world among patients younger than 50 years, and encouraging more people to screen could be key in tackling this problem.

Recommended News For You

investigating radiation oncology applications of artificial general intelligence.

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

A protein with new anticancer activity has been identified

Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

Recommended Articles For You

Hematology Laboratory Simulation: Advancing Clinical Competence through Technology-Driven Training 

The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies 

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium 

Public Health Through Cancer Survivorship Infrastructure at the Community Level 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.

2.

Researchers discuss HER2-low and HER2-zero in breast cancer

3.

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.

4.

Delay of more than 42 days for breast cancer surgery raises death risk for certain subtypes, study finds

5.

Waiting for a Sharp Increase in Prostate Cancer Cases.

1.

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment

2.

Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics

3.

Unlocking the Mysteries of the Axillary Vein: Exploring its Role in Human Anatomy

4.

How HLH is Revolutionizing Healthcare

5.

Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

How Advances in Cancer Research Are Improving Treatment Options

2.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

3.

Navigating the Complexities of Ph Negative ALL - Part XIV

4.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot